
GLP-1s and the ‘Wild West’ of Wellness
Here’s a shocking number: One out of eight American adults is taking a GLP-1, like Ozempic or Zepbound, according to a KFF poll. GLP-1s are the biggest pharmaceutical story since antidepressants. But there’s still so much we don’t know. “We’re only at the beginning of what’s been called this Ozempic era,” the journalist Julia Belluz told me. “I think we’re really just at the beginning of discovering the benefits and the harms of these drugs.” These discoveries begin in the research but are also expanding into how we think about our puni...
Publisher
The Ezra Klein Show
Link
www.nytimes.com/2026/05/08/opinion/ezra-klein-podcast-julia-belluz.html
Published
May 8, 2026
Duration
1h 14m
Format
Podcast
Category
Lifestyle · Culture
Source
RSS feed
Host
New York Times Opinion
The Ezra Klein Show
@ezraklein
#wildwest #wellness
